Serum opacity factor (SOF) of Streptococcus pyogenes evokes antibodies that opsonize homologous and heterologous SOF-positive serotypes of group A streptococci

被引:48
作者
Courtney, HS
Hasty, DL
Dale, JB
机构
[1] Univ Tennessee, Vet Adm Med Ctr, Res Serv 151, Memphis, TN 38104 USA
[2] Univ Tennessee, Dept Med, Memphis, TN 38104 USA
[3] Univ Tennessee, Dept Anat & Neurobiol, Memphis, TN 38104 USA
关键词
D O I
10.1128/IAI.71.9.5097-5103.2003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Serum opacity factor (SOF) is a protein expressed by Streptococcus pyogenes that opacifies mammalian serum. SOF is also a virulence factor of S. pyogenes, but it has not been previously shown to elicit a protective immune response. Herein, we report that SOF evokes bactericidal antibodies against S. pyogenes in humans, rabbits, and mice. Rabbit antiserum against purified recombinant SOF2 opsonized SOF-positive M type 2, 4, and 28 S. pyogenes in human blood but had no effect on SOF-negative M type 5 S. pyogenes. Furthermore, affinity-purified human antibodies against SOF2 also opsonized SOF-positive streptococci. A combination of antisera against M2 and SOF2 proteins was dramatically more effective in killing streptococci than either antiserum alone, indicating that antibodies against SOF2 enhance the opsonic efficiency of M protein antibodies. Mice tolerated an intravenous injection of 100 mug of SOF without overt signs of toxicity, and immunization with SOF protected mice against challenge infections with M type 2 S. pyogenes. These data indicate that SOF evokes opsonic antibodies that may protect against infections by SOF-positive serotypes of group A streptococci and suggest that different serotypes of SOF have common epitopes that may be useful vaccine candidates to protect against group A streptococcal infections.
引用
收藏
页码:5097 / 5103
页数:7
相关论文
共 48 条
[21]   Immunological response mounted by Aboriginal Australians living in the Northern Territory of Australia against Streptococcus pyogenes serum opacity factor [J].
Gillen, CM ;
Towers, RJ ;
McMillan, DJ ;
Delvecchio, A ;
Sriprakash, KS ;
Currie, B ;
Kreikemeyer, B ;
Chhatwal, GS ;
Walker, MJ .
MICROBIOLOGY-SGM, 2002, 148 :169-178
[22]   Protective immune response against Streptococcus pyogenes in mice after intranasal vaccination with the fibronectin binding protein SfbI [J].
Guzmán, CA ;
Talay, SR ;
Molinari, G ;
Medina, E ;
Chhatwal, GS .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (04) :901-906
[23]   Immunogenicity of a 26-valent group A streptococcal vaccine [J].
Hu, MC ;
Walls, MA ;
Stroop, SD ;
Reddish, MA ;
Beall, B ;
Dale, JB .
INFECTION AND IMMUNITY, 2002, 70 (04) :2171-2177
[24]   EXPRESSION OF THE ARP PROTEIN, A MEMBER OF THE M-PROTEIN FAMILY, IS NOT SUFFICIENT TO INHIBIT PHAGOCYTOSIS OF STREPTOCOCCUS-PYOGENES [J].
HUSMANN, LK ;
SCOTT, JR ;
LINDAHL, G ;
STENBERG, L .
INFECTION AND IMMUNITY, 1995, 63 (01) :345-348
[25]   Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by the group A Streptococcus [J].
Ji, YD ;
Carlson, B ;
Kondagunta, A ;
Cleary, PP .
INFECTION AND IMMUNITY, 1997, 65 (06) :2080-2087
[26]   VACCINATION WITH STREPTOCOCCAL EXTRACELLULAR CYSTEINE PROTEASE (INTERLEUKIN-1-BETA CONVERTASE) PROTECTS MICE AGAINST CHALLENGE WITH HETEROLOGOUS GROUP-A STREPTOCOCCI [J].
KAPUR, V ;
MAFFEI, JT ;
GREER, RS ;
LI, LL ;
ADAMS, GJ ;
MUSSER, JM .
MICROBIAL PATHOGENESIS, 1994, 16 (06) :443-450
[27]   Systemic and mucosal immunizations with fibronectin-binding protein FBP54 induce protective immune responses against Streptococcus pyogenes challenge in mice [J].
Kawabata, S ;
Kunitomo, E ;
Terao, Y ;
Nakagawa, I ;
Kikuchi, K ;
Totsuka, KI ;
Hamada, S .
INFECTION AND IMMUNITY, 2001, 69 (02) :924-930
[28]   CHARACTERIZATION OF A NOVEL FIBRONECTIN-BINDING SURFACE PROTEIN IN GROUP-A STREPTOCOCCI [J].
KREIKEMEYER, B ;
TALAY, SR ;
CHHATWAL, GS .
MOLECULAR MICROBIOLOGY, 1995, 17 (01) :137-145
[29]  
Kreikemeyer B, 1999, FEMS MICROBIOL LETT, V178, P305, DOI 10.1016/S0378-1097(99)00373-0